Genomic instabillity is a characteristic of practically all human cancers. GENICA, a Seventh Framework Health Research Programme supported by the European Union, attempts to understand the molecular basis of genomic instability in human cancer. Such knowledge is expected to lead to better cancer diagnoses and therapies.